M. Abbehusen

Immunization of Experimental Dogs With Salivary Proteins From Lutzomyia longipalpis, Using DNA and Recombinant Canarypox Virus Induces Immune Responses Consistent With Protection Against Leishmania infantum

P. Bozza, S. Kamhawi, J. Valenzuela, 2018, Front. Immunol..

Clinical and immunopathological findings during long term follow-up in Leishmania infantum experimentally infected dogs

P. Bozza, M. S. Solcà, C. Brodskyn, 2017, Scientific Reports.

Circulating Biomarkers of Immune Activation, Oxidative Stress and Inflammation Characterize Severe Canine Visceral Leishmaniasis

R. Khouri, P. Bozza, S. Kamhawi, 2016, Scientific Reports.

Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.

Y. Goto, S. Reed, E. Netto, 2010, Vaccine.

Vaccination with Leishmania infantum Acidic Ribosomal P0 but Not with Nucleosomal Histones Proteins Controls Leishmania infantum Infection in Hamsters

C. Brodskyn, W. Dos-Santos, M. Barral-Netto, 2015, PLoS neglected tropical diseases.

Immunization with LJM11 salivary protein protects against infection with Leishmania braziliensis in the presence of Lutzomyia longipalpis saliva.

J. Valenzuela, C. Brodskyn, M. Abbehusen, 2018, Acta tropica.

Experimental Infection of Dogs with Leishmania and Saliva as a Model to Study Canine Visceral Leishmaniasis

J. C. Miranda, C. Brodskyn, A. L. Abreu-Silva, 2013, PloS one.

Clinical and immunopathological findings during long term follow-up in Leishmania infantum experimentally infected dogs

P. Bozza, C. Brodskyn, P. Veras, 2017, Scientific Reports.